News - Page 194 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Red Light Holland Closes Acquisition of SR Wholesale Becoming a Leader in Distribution of Psychedelics

Red Light Holland Closes Acquisition of SR Wholesale Becoming a Leader in Distribution of Psychedelics

Post published:March 19, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Australian Gov Earmarks $15m for Psychedelic Studies; Otsuka Licences R-ketamine in Japan; DC Initiative Becomes Law

Psychedelic Bulletin: Australian Gov Earmarks $15m for Psychedelic Studies; Otsuka Licences R-ketamine in Japan; DC Initiative Becomes Law

Post published:March 19, 2021
Post category:Psychedelic Bulletin

Read more about the article Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM’s AI-Driven Psychedelic Digital Therapeutic Technology

Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM’s AI-Driven Psychedelic Digital Therapeutic Technology

Post published:March 19, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application

Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application

Post published:March 19, 2021
Post category:Press Release

Read more about the article Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Post published:March 18, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics

Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics

Post published:March 18, 2021
Post category:Press Release

Read more about the article atai Life Sciences AG Announces Equity Investment in and Strategic Partnership with IntelGenx Technologies Corp.

atai Life Sciences AG Announces Equity Investment in and Strategic Partnership with IntelGenx Technologies Corp.

Post published:March 17, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering

Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering

Post published:March 17, 2021
Post category:Press Release

Read more about the article Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20th Pre-Clinical Study

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20th Pre-Clinical Study

Post published:March 17, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing

Post published:March 17, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.